Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Updates from the EMBRACA trial for advanced breast cancer

Prof Hope Rugo - University of California, San Francisco, USA
Updates from the EMBRACA trial for advanced breast cancer ( Prof Hope Rugo - University of California, San Francisco, USA )
24 Oct 2018

Tumour-infiltrating lymphocytes (TILs) as an independent prognostic factor for early HER2 positive breast cancer

Dr Maria Vittoria Dieci - University of Padua, Padova, Italy
Tumour-infiltrating lymphocytes (TILs) as an independent prognostic factor for early HER2 positive breast cancer ( Dr Maria Vittoria Dieci - University of Padua, Padova, Italy )
24 Oct 2018

Neoadjuvant ipilimumab plus nivolumab in early stage colon cancer

Dr Myriam Chalabi - Netherlands Cancer Institute, Amsterdam, Netherlands
Neoadjuvant ipilimumab plus nivolumab in early stage colon cancer ( Dr Myriam Chalabi - Netherlands Cancer Institute, Amsterdam, Netherlands )
22 Oct 2018

Updates in head and neck cancers

Prof Jean-Pascal Machiels - University Clinic Saint-Luc, Brussels, Belgium
Updates in head and neck cancers ( Prof Jean-Pascal Machiels - University Clinic Saint-Luc, Brussels, Belgium )
22 Oct 2018

KEYNOTE022: Triplet therapy for BRAF melanoma

Prof Paolo Ascierto - Istituto Nazionale Tumori - IRCCS "Fondazione G.Pascale", Milan, Italy
KEYNOTE022: Triplet therapy for BRAF melanoma ( Prof Paolo Ascierto - Istituto Nazionale Tumori - IRCCS "Fondazione G.Pascale", Milan, Italy )
22 Oct 2018

First-line pembrolizumab for recurrent/metastatic head and neck squamous cell carcinoma

Prof Barbara Burtness - Yale University School of Medicine and Yale Cancer Center New Haven, USA
First-line pembrolizumab for recurrent/metastatic head and neck squamous cell carcinoma ( Prof Barbara Burtness - Yale University School of Medicine and Yale Cancer Center New Haven, USA )
22 Oct 2018

ESMO 2018: Melanoma highlights

Dr Teresa Amaral, Will Davies
ESMO 2018: Melanoma highlights ( Dr Teresa Amaral, Will Davies )
22 Oct 2018

IMpower130: PFS and safety of adding atezolizumab to first-line NSCLC therapy

Dr Federico Cappuzzo - AUSL della Romagna-Ravenna, Ravenna, Italy
IMpower130: PFS and safety of adding atezolizumab to first-line NSCLC therapy ( Dr Federico Cappuzzo - AUSL della Romagna-Ravenna, Ravenna, Italy )
22 Oct 2018

KEYNOTE048: First line pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma

Prof Barbara Burtness - Yale Cancer Center, New Haven, USA
KEYNOTE048: First line pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma ( Prof Barbara Burtness - Yale Cancer Center, New Haven, USA )
22 Oct 2018

ESMO 2018: Highlights

Prof Gordon McVie , Will Davies
ESMO 2018: Highlights ( Prof Gordon McVie , Will Davies )
22 Oct 2018

IMpassion 130 trial results: Immunotherapy for metastatic breast cancer

Prof Peter Schmid - St Bartholomew Hospital London, UK
IMpassion 130 trial results: Immunotherapy for metastatic breast cancer ( Prof Peter Schmid - St Bartholomew Hospital London, UK )
22 Oct 2018

The TRIBE-2 study for colorectal cancer

Dr Chiara Cremolini - Università di Pisa, Pisa, Italy
The TRIBE-2 study for colorectal cancer ( Dr Chiara Cremolini - Università di Pisa, Pisa, Italy )
22 Oct 2018